iRemedy
iRemedy Advises “Project Vaccinate” Program is Gaining Traction in 2021 With Over 130 Million Needles and Syringes Delivered
iRemedy announced that in association with the Company’s effort to procure and deliver one billion FDA-approved hypodermic needles and syringes in support of COVID-19 vaccination programs worldwide, over 130 million units have been delivered to customers since announcing its program in November 2020.
